Pavla Kadlecová

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Heinz Gisslinger, Oleh Zagrijtschuk, Veronika Buxhofer‐Ausch et al. · Blood · 2015 · 176 citations · Full text

Aganirsen Antisense Oligonucleotide Eye Drops Inhibit Keratitis-Induced Corneal Neovascularization and Reduce Need for Transplantation

Claus Cursiefen, Eric Viaud, Felix Bock et al. · Ophthalmology · 2014 · 109 citations · Full text

Factors Influencing In-Hospital Delay in Treatment With Intravenous Thrombolysis

Robert Mikulík, Pavla Kadlecová, Anna Członkowska et al. · Stroke · 2012 · 108 citations · Full text

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 82 citations · Full text

Midlife Alcohol Consumption and Risk of Dementia Over 43 Years of Follow-Up: A Population-Based Study From the Swedish Twin Registry

Elizabeth P. Handing, Ross Andel, Pavla Kadlecová et al. · The Journals of Gerontology Series A · 2015 · 69 citations